If a medicine is offered for your gut problem, ask what studies support that use. Ask separately whether the medicine may legally be made and prescribed for you.
Peptides are short chains made from the same tiny chemical parts as proteins. That name alone does not tell you what a treatment does.
Beside the evidence
An offer mentioning BPC-157
By September 2026, BPC-157 had no application for US approval with the Food and Drug Administration (FDA), the drug regulator.
FDA says human safety information for this substance is too limited to establish whether it could cause harm.
Ask which request the word refers to, and what it changes for the product being offered.
Was this an approval decision or a request taken back?
What makes it legal to prepare this particular medicine and prescribe it for my problem?
Can the clinician show the source rather than just a headline?
Beside the evidence
The request and the medicine are different things
April 22, 2026 is the date marked “current as of” on the FDA page. That page names BPC-157 and another peptide, KPV. People had asked FDA to list them as ingredients for medicines made to order, then took those requests back.
In the September 2026 record, taking back those requests gave no approval or permission to make these peptides into medicines.
BPC-157 and KPV do not meet the ingredient rules for medicines made for individual patients. BPC-157 and KPV appear in the Health and Human Services draft published October 30, 2026. HHS would refrain from penalizing state-licensed pharmacies and licensed doctors making either alone for a patient’s prescription if the draft’s conditions are met.